David Healthcare (300314.SZ): Net profit of 38.1072 million yuan in the first quarter decreased by 23.81% year-on-year

On April 19, Ge Longhui (300314.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 155 million yuan, down 1.61% year on year; net profit attributable to shareholders of listed companies was 38.1072 million yuan, down 23.81% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 394.438 million yuan, down 11.14% year on year; basic earnings per share were 0.1323 yuan.

Gelonghui FinanceApr 19 15:55

David Medical (300314.SZ): Pediatric obstetrics care equipment has now entered more than 600 of the top three hospitals in China

Gelonghui, April 16 | David Medical (300314.SZ) said at an investor relations event that the company's pediatric obstetrics care equipment has now entered more than 600 domestic hospitals, has agents in more than 30 provinces, cities and autonomous regions, and provides technology, products and services to more than 140 countries and regions around the world; the company's minimally invasive surgical instruments have entered more than 400 domestic hospitals, and the foreign market covers 83 countries and regions. Currently, there are a total of 29 research projects. For details, please refer to the company's 2023 report.

Gelonghui FinanceApr 16 20:01

Open Source Securities released a research report on April 10 stating that it gave David Healthcare (300314.SZ) a purchase rating. The main reasons for the rating include: 1) Endoscopy and electrification of staplers are already popular, and the collectio

Open Source Securities released a research report on April 10 stating that it gave David Healthcare (300314.SZ) a purchase rating. The main reasons for the rating include: 1) Endoscopy and electrification of staplers are already popular, and the collection policy is expected to increase the penetration rate and localization rate of electric kettles; 2) the subsidiary Vilkady uses the power of harvesting to speed up the release of staplers and forward-looking layout of first aid products. (Mainichi Keizai Shimbun)

Zhitong FinanceApr 10 13:39

David Healthcare (300314.SZ) announced its 2023 annual results, with net profit of 148 million yuan, an increase of 51.62%

David Healthcare (300314.SZ) released its 2023 annual report. The company's revenue was 618 million yuan, an increase of 22.18% over the previous year. Net profit attributable to shareholders of listed companies was 148 million yuan, an increase of 51.62% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was $129 million, an increase of 61.78% over the previous year. Basic earnings per share were $0.51.

Zhitong FinanceApr 8 19:25

David Healthcare (300314.SZ): As of February 29, 2024, the total number of shareholders of the company is about 16,300

On March 5, Ge Longhui | David Healthcare (300314.SZ) said on the investor interactive platform that as of February 29, 2024, the total number of shareholders of the company was about 16,300.

Gelonghui FinanceMar 5 15:10

David Medical (300314.SZ): Currently, Vercady endoscopic staplers have entered more than 300 domestic hospitals

On March 5, Ge Longhui | David Medical (300314.SZ) said on the investor interactive platform that at present, Virkaidi endoscopic staplers have entered more than 300 domestic hospitals, mainly in the top three hospitals.

Gelonghui FinanceMar 5 15:09